4 assets in Embryonal Carcinoma

Therapeutic assets addressing Embryonal Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Bleomycin Embryonal Carcinoma	Children's Oncology Group	P3	B (60)
Carboplatin Embryonal Carcinoma	Children's Oncology Group	P3	B (60)
Cis-Diamminedichloroplatinum Ii Embryonal Carcinoma	Children's Oncology Group	P3	B (60)
Etoposide Embryonal Carcinoma	Children's Oncology Group	P3	B (60)